ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2015
Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany.
Jan Steffen Jürgensen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papertrialcites it